388 related articles for article (PubMed ID: 22521711)
1. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems.
Papadimitriou SA; Achilias DS; Bikiaris DN
Int J Pharm; 2012 Jul; 430(1-2):318-27. PubMed ID: 22521711
[TBL] [Abstract][Full Text] [Related]
2. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
Csaba N; Köping-Höggård M; Alonso MJ
Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
[TBL] [Abstract][Full Text] [Related]
3. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
4. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
5. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
6. Optimization of self-assembling properties of fatty acids grafted to methoxy poly(ethylene glycol) as nanocarriers for etoposide.
Varshosaz J; Hasanzadeh F; Eslamdoost M
Acta Pharm; 2012 Mar; 62(1):31-44. PubMed ID: 22472447
[TBL] [Abstract][Full Text] [Related]
7. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
9. pH and dual redox responsive nanogel based on poly(l-glutamic acid) as potential intracellular drug carrier.
Ding J; Xiao C; Yan L; Tang Z; Zhuang X; Chen X; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e11-3. PubMed ID: 22195786
[No Abstract] [Full Text] [Related]
10. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
11. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
Lin CC; Fu CH
Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of aspirin/chitosan nanoparticles by nucleation and ionic crosslinking in micro emulsions.
Jin S; Feng L; Yu X
J Control Release; 2011 Nov; 152 Suppl 1():e39-41. PubMed ID: 22195912
[No Abstract] [Full Text] [Related]
13. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
14. Monodisperse chitosan nanoparticles for mucosal drug delivery.
Zhang H; Oh M; Allen C; Kumacheva E
Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
[TBL] [Abstract][Full Text] [Related]
15. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.
Vandana M; Sahoo SK
Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
Wang S; Jiang T; Ma M; Hu Y; Zhang J
Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-based membranes with different ionic crosslinking density for pharmaceutical and industrial applications.
Gierszewska M; Ostrowska-Czubenko J
Carbohydr Polym; 2016 Nov; 153():501-511. PubMed ID: 27561522
[TBL] [Abstract][Full Text] [Related]
18. Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer.
Csaba N; Köping-Höggård M; Fernandez-Megia E; Novoa-Carballal R; Riguera R; Alonso MJ
J Biomed Nanotechnol; 2009 Apr; 5(2):162-71. PubMed ID: 20055094
[TBL] [Abstract][Full Text] [Related]
19. Delivery of protein drugs using nanoparticles self-assembled from dextran sulfate and quaternized chitosan.
Shu S; Zhang X; Wu Z; Wang Z; Li C
J Control Release; 2011 Nov; 152 Suppl 1():e170-2. PubMed ID: 22195830
[No Abstract] [Full Text] [Related]
20. A novel method for the synthesis of the PEG-crosslinked chitosan with a pH-independent swelling behavior.
Kulkarni AR; Hukkeri VI; Sung HW; Liang HF
Macromol Biosci; 2005 Oct; 5(10):925-8. PubMed ID: 16208628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
